MDMG.L Regulatory News (MDMG)

MD MEDICAL GROUP REPORTS 14% DELIVERIES GROWTH IN 1H 2013

22 August 2013, Moscow, Russia - MD Medical Group Investments Plc (LSE: MDMG) (the "Group"), Russia's leading provider of private women's and children's healthcare, announces operating results for the half year ended 30 June 2013[1].

Elena Mladova, Chief Executive Officer of MD Medical Group, said:

"We are pleased to post strong operating results for the period, with double-digit growth across all of our key performance indicators. Three factors in particular contributed to this growth.

"We have continued to expand our geographic footprint across Russia, for example with the successful acquisition of IDK Samara.

"We have expanded the range of our inpatient and outpatient services, with the opening of surgery, trauma and rehabilitation departments as well as a new diagnostics centre at Lapino hospital.

"And we continue to demonstrate leadership in developing new and innovative technologies within women's health and pediatrics. We were pleased, for example, to have become the first company to offer Laparoscopic removal of abdominal cerclage."

During the reporting period, the total number of deliveries increased by 14% from 1,570 to 1,792, outpacing the birth rate growth in Moscow (+1.3%) and Moscow region (+1.1%). The main driver for this growth was the successful ramp up at Lapino, with 521 deliveries in the first half of 2013. The number of deliveries at Perinatal Medical Centre (PMC) amounted to 1,271, a 19% y-o-y decrease on the back of strong base effect from the previous year, and approximately in line with the total annual deliveries during the three previous years - 2009-2011. The number of outpatient treatments in the first half of 2013 increased by 32% to 273,910, up from 207,949 in the same period last year.

Inpatient admissions in the first half of 2013 grew by 18% to 13,992, up from 11,882 year-on-year.

IVF cycles increased by 20% during the reporting period, reaching a total of 2,335.

1H 2013 Operating Highlights

ENDS

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages ten modern healthcare facilities, including two hospitals and eight outpatient clinics in Moscow, St. Petersburg, Ufa, Irkutsk and Perm. In addition, two franchised outpatient clinics operate in Kyiv.

The Company's main medical facilities are the Perinatal Medical Center (PMC), a 250-bed medical centre, which opened its doors in 2006, and Lapino hospital, a 182-bed medical centre, which opened at the end of 2012. In 2012, there were 3,253 deliveries in PMC and Lapino. The number of outpatient treatments for 2012 in PMC and the Company's outpatient clinics totalled 446,407. In March 2013, the Company began construction of its third hospital in Ufa. In April 2013 MD Medical Group completed the acquisition of the IDK Medical Company, a network of women's and children's health clinics located in the Russian region of Samara ("IDK"). In May 2013, the Company acquired Mother&Child clinic in Irkutsk, which previously has operated through a franchise agreement with MD Medical Group.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

* * *

Forward-Looking Statements:

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.